A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria
Clinical trial NCT06603220 · COMPLETED
Trial details
- NCT number
- NCT06603220
- Sponsor
- Evommune, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-14
- Primary completion
- 2025-05-08
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.